BRTX
NASDAQ · Biotechnology
Biorestorative Therapies Inc
$0.21
+0.01 (+4.48%)
Open$0.21
Previous Close$0.20
Day High$0.22
Day Low$0.21
52W High$1.89
52W Low$0.16
Volume—
Avg Volume513.7K
Market Cap5.20M
P/E Ratio—
EPS$-1.09
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+12,361.9% upside
Current
$0.21
$0.21
Target
$26.17
$26.17
$18.72
$26.17 avg
$39.89
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.00M | 693.6K | 1.76M |
| Net Income | -39,592,858 | -24,714,642 | 288.6K |
| Profit Margin | -3,959.4% | -3,761.4% | 16.4% |
| EBITDA | -42,912,888 | -28,275,241 | 503.0K |
| Free Cash Flow | — | — | 335.8K |
| Rev Growth | +44.2% | +44.2% | +14.5% |
| Debt/Equity | — | — | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.68 | -0.45% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $412.84 | -1.20% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.12 | -0.01% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $508.33 | -1.57% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $803.64 | -0.29% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $227.29 | +0.07% | 35.2 | 28.41B |